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Abstract 32 
Plasma concentrations of the stable endothelin-1 precursor, CT-proET-1, determined 33 
prospectively in 293 newborn infants (gestational age 24 - 41 weeks) at birth and on 34 
day 3 of life, were unrelated to gestational age at birth but strongly associated with 35 
respiratory distress when measured on day 3 of life. 36 
 37 
Introduction 38 
Endothelin-1 is secreted by endothelial cells and acts as a potent vasoconstrictor (1). 39 
Raised plasma concentrations of endothelin-1 have been related to respiratory 40 
morbidity (1), including respiratory distress syndrome in newborn infants (2-5). 41 
Whereas endothelin-1 is unstable and therefore unsuited for diagnostic use, its 42 
secretion can be estimated by measuring CT-proET-1, the C-terminal portion of the 43 
endothelin-1 precursor (6, 7). The objective of this prospective study was to 44 
investigate the association between levels of circulating CT-proET-1 at birth and on 45 
day 3 of life and perinatal morbidity in preterm and term infants.  46 
 47 
Subjects and methods 48 
This cross-sectional study was performed between March 2009 and December 2010, 49 
enrolling a total of 293 infants born at the University Hospitals of Basel and Zürich, 50 
both Switzerland, after written informed parental consent. The Ethics Committees of 51 
Basel and Zürich approved the study protocol.  52 
Blood samples were drawn from 256 umbilical veins at the time of delivery, with 53 
additional 83 paired samples from the umbilical artery and 90 paired blood samples 54 
from postnatal day 3. Samples were also taken from 37 unrelated infants on 55 
postnatal day 3 only. Blood sampling and processing as well as collection of clinical 56 
data have been described previously (8). Respiratory distress syndrome (RDS) was 57 
 3 
classified according to chest x-ray findings. Bronchopulmonary dysplasia (BPD) was 58 
considered mild in infants requiring supplemental oxygen at a chronological age of 28 59 
days, and moderate in infants requiring supplemental oxygen at a postmenstrual age 60 
of 36 weeks. CT-proET-1 (pmol/L) was measured in a single batch with BRAHMS 61 
KRYPTOR automated immunoflorescent assay (BRAHMS Biomarkers, Thermo 62 
Fisher Scientific, Hennigsdorf, Germany) (6). Continuous variables are reported as 63 
median (M) and range. Data were analyzed using Mann-Whitney U test, Kruskal-64 
Wallis test, Fisher’s exact test, and Spearman’s rank order correlation coefficient (RS) 65 
as appropriate employing SPSS 19.0 (SPSS, Chicago, Ill.). A p-value < 0.05 was 66 
considered statistically significant. 67 
 68 
Results  69 
Baseline characteristics of infants enrolled, split by gestational age (preterm vs. 70 
term), are shown in Table 1. 71 
At birth, CT-proET-1 concentrations were unrelated to birth weight (BW) and 72 
gestational age (GA) (Fig 1A). Venous umbilical cord CT-proET-1 concentrations 73 
were consistently higher than matched arterial ones (M 148 vs. 134 pmol/L, 74 
p<0.001), but both values were closely related (RS=0.745, p<0.001, n=83).  75 
Umbilical cord CT-proET-1 concentrations (n=256) were slightly increased in infants 76 
with compromized placental perfusion (M 156 vs. 142 pmol/L, p=0.015, n=137) and 77 
infants born to mothers with preeclampsia (M 163 vs. 144 pmol/L, p=0.032, n=256). 78 
Delivery mode or signs of fetal distress immediately before birth (low arterial umbilical 79 
cord pH, suspect fetal heart tracing) and infections (i.e. maternal signs of infection at 80 
delivery, histologically proven chorioamnionitis, and neonatal bloodstream-proven 81 
sepsis) had no effect on CT-proET-1 at birth.  82 
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In contrast to CT-proET-1 at birth, CT-proET-1 on day 3 of life was inversely related 83 
to BW (RS -0.610) and GA (RS -0.649) (n=127, p<0.001) (Fig 1B), due to a profound 84 
postnatal increase in CT-proET-1 concentrations in preterm infants with respiratory 85 
morbidity. When investigating the association between CT-proET-1 and respiratory 86 
morbidity in preterm infants, we found that days of mechanical ventilation, continuous 87 
positive airway pressure (CPAP), and oxygen supplementation correlated each with 88 
CT-proET-1 level on day 3 (RS 0.566, 0.658, and 0.819, respectively, for all p<0.001). 89 
Increasing levels of respiratory support in the first 3 days of life (none, CPAP only, 90 
endotracheal ventilation) were associated with increasing circulating concentrations 91 
of CT-proET-1 concentrations on day 3 (Figure 1C). A very similar association was 92 
found between degree of respiratory distress syndrome (radiological diagnosis) and 93 
CT-proET-1 concentrations on day 3 (Figure 1D).  94 
Infants developing mild BPD had higher CT-proET-1 concentrations on day 3 than 95 
those without mild BPD (M/range 345 (219-537) pmol/L, n=11 vs. 194 (35-727) 96 
pmol/L, n=63; p<0.001), and infants developing moderate/severe BPD had higher 97 
CT-proET-1 concentrations on day 3 than those without moderate/severe BPD (387 98 
(219-537) pmol/L, n=6 vs. 202 (35-727) pmol/L n=63; p=0.011). Multivariate logistic 99 
regression analysis, however, failed to establish CT-proET-1 on day 3 as an 100 
independent predictor of mild or moderate/severe BPD. 101 
 102 
103 
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Discussion 104 
This study demonstrates that CT-proET-1 concentrations in umbilical cord blood at 105 
birth are unaffected by GA (Fig 1A). Compromized placental perfusion appears to be 106 
associated with slightly elevated CT-proET-1 concentrations at birth. CT-proET-1 107 
concentrations rose strongly from birth to day 3 of life in infants with RDS but not 108 
infants without respiratory disease (Fig 1C). Moreover, CT-proET-1 on day 3 of life 109 
was associated with radiological degree of RDS suggesting a dose-response 110 
relationship (Fig 1D). CT-proET-1, however, was not predictive of BPD after adjusting 111 
for GA.  112 
An early increase in endothelin-1 has been shown to be a prognostic factor for BPD 113 
when endothelin-1 in tracheal aspirate was measured on day 7 of life (9). In our 114 
study, plasma CT-proET-1 concentrations were measured on day 3 of life which may 115 
reduce prognostic power compared to measurement on day 7. Moreover, we cannot 116 
exclude a type 2 error given that only 11 infants who had CT-proET-1 measurements 117 
on day 3 were diagnosed with mild BPD and 6 with moderate/severe BPD. It remains 118 
nevertheless intriguing to speculate that determining plasma CT-proET-1 within the 119 
first week of life may help to identify infants at risk of BPD. Functional data on 120 
endothelin-1 action (10) denote that endothelin-1 is not only a marker but a mediator 121 
of respiratory disease in newborn infants. These insights provide the framework for 122 
further studies investigating endothelin-1 action in newborn infants compromised by 123 
respiratory distress. 124 
 125 
List of abbreviations: 126 
CPAP  Continuous positive airway pressure 127 
CT-proET-1 C-terminal prohormone ET-1 128 
BW  Birth weight 129 
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GA  Gestational age 130 
M  Median 131 
RDS  Respiratory distress syndrome  132 
BPD  Bronchopulmonary dysplasia133 
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Figure legend 164 
Figure 1: Scatter plots of gestational age versus CT-proET-1 plasma concentrations 165 
in newborn infants determined at birth in venous umbilical cord blood (A) and at day 166 
3 of life (B). Box (interquartile range) and whisker (5-95 % range) plots of CT-proET-1 167 
plasma concentrations on day 3 in preterm infants (gestational age < 37 weeks) 168 
according to level of respiratory support (C) and severity of respiratory distress 169 
syndrome (RDS, D).  170 
 171 
Table 1. Subjects and perinatal characteristics 
  GA 24-36 weeks GA 37-41 weeks  
 
p 
  
n 
n (%) or 
M (range) 
 
n 
n (%) or 
M (range) 
 
n 
Maternal characteristics       
- Signs of infection at delivery 293 32 (19) 165 1 (1) 128 <0.001 
- Preeclampsia 293 45 (27) 165 3 (2) 128 <0.001 
- Vaginal/abdominal delivery 293 127/38 (77/23) 165 77/51 (60/40) 128 0.002 
Fetal characteristics       
- SGA (<5
th
 P) 293 37 (22) 165 13 (10) 128 0.011 
- Suspect CTG just prior to delivery 293 52 (32) 165 40 (31) 128 n.s. 
Placentae, histological examination       
- Compromised perfusion 149 52 (40) 131 0 (0) 18 n.s. 
- Chorioamnionitis 149 20 (15) 131 9 (50) 18 n.s. 
Neonatal characteristics       
- Gestational age (weeks) 293 32.4 (24.4/36.9) 165 39.0 (37.0/41.9) 128 <0.001 
- Birth weight (kg) 293 1.7 (0.4/3.7) 165 3.4 (1.9/4.8) 128 <0.001 
- Arterial cord blood pH 274 7.31 (6.92/7.45) 153 7.30 (7.03/7.53) 121 0.001 
- Apgar score at 5 min 293 8 (2/10) 165 9 (3/10) 128 <0.001 
- Male gender 293 91 (55) 165 76 (59) 128 n.s. 
Postnatal course until day 3 of life       
- Endotracheal ventilation 293 29 (18) 165 0 (0) 128 <0.001 
- Any positive pressure support 293 79 (48) 165 0 (0) 128 <0.001 
- RDS °1 or wet lung 293 60 (36) 165 0 (0) 128 <0.001 
- RDS °2-4  293 38 (23) 165 0 (0) 128 <0.001 
- Sepsis with positive blood culture 293 7 (4) 165 0 (0) 128 0.02 
- PDA treated 293 31 (19) 165 0 (0) 128 <0.001 
- Intraventricular hemorrhage >°1 120 6 (5) 120 0 (0) 0 n.s. 
Postnatal course until discharge       
- Mild BPD 293 17 (10) 165 0 (0) 128 <0.001 
- Moderate/severe BPD 293 8 (5) 165 0 (0) 128 0.011 
- Death 293 9 (5) 165 0 (0) 128 0.006 
CT-proET-1 (pmol/L)       
- At birth, venous cord blood 256 143 (34/328) 150 149 (63/230) 106 n.s. 
- On day 3 of life  127 219 (35/727) 69 129 (38/189) 58 <0.001 
GA, gestational age, SGA, small for gestational age; M, median; CTG, cardiotocogram, fetal heart rate 
tracing; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; BPD, bronchopulmonary 
dysplasia; mild BPD, oxygen until day 28 of life; moderate/severe BPD, oxygen at 36 weeks 
postmenstrual age. Characteristics were compared using Mann-Whitney U test or Fisher's exact test 
as appropriate. n.s., p > 0.05. 
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